Role of inflammation in tbulo-interstitial damage associated to obstructive nephropathy

Journal of Inflammation

Volumn 7, Issue , 2010, Pages

  Grande, María T ^a,b   Pérez Barriocanal, Fernando ^a,b   Lápez Novoa, José M ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 [5 CHLORO 2 [2 [4 (4 FLUOROBENZYL) 2 METHYL 1 PIPERAZINYL] 2 OXOETHOXY]PHENYL]UREA; ADENOSINE RECEPTOR STIMULATING AGENT; ANGIOTENSIN II; ATORVASTATIN; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR2; CURCUMIN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTEGRIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ISOTRETINOIN; LOSARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRIC OXIDE; OSTEOPONTIN; PARICALCITOL; PROTEASOME INHIBITOR; RAPAMYCIN; SCATTER FACTOR; SELECTIN; SIMVASTATIN; TOCOPHEROL DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

APOPTOSIS; CELL DAMAGE; CELL INFILTRATION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MECHANISM; GENE OVEREXPRESSION; HUMAN; INFLAMMATION; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; LEUKOCYTE ADHERENCE INHIBITION; LEYDIG CELL; MACROPHAGE ACTIVATION; MYOFIBROBLAST; NONHUMAN; OBSTRUCTIVE NEPHROPATHY; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; URETER OBSTRUCTION; URINARY TRACT OBSTRUCTION;

EID: 77951080823     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-7-19     Document Type: Review

References (137)

1. Contributions of the Transplant Registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). JM Smith DM Stablein R Munoz D Hebert RA McDonald, Pediatr Transplant 2007 11 366 373 10.1111/j.1399-3046.2007.00704.x 17493215
2. Obstructive nephropathy and renal fibrosis. S Klahr J Morrissey, Am J Physiol Renal Physiol 2002 283 861 F875 12372761
3. Obstructive nephropathy. S Klahr, Intern Med 2000 39 355 361 10.2169/internalmedicine.39.355 10830173
4. Obstructive nephropathy: towards biomarker discovery and gene therapy. RL Chevalier, Nat Clin Pract Nephrol 2006 2 157 168 10.1038/ncpneph0098 16932414
5. Evidence that fibroblasts derive from epithelium during tissue fibrosis. M Iwano D Plieth TM Danoff C Xue H Okada EG Neilson, J Clin Invest 2002 110 341 350 12163453
6. Fibroblast activation and myofibroblast generation in obstructive nephropathy. MT Grande JM Lápez-Novoa, Nat Rev Nephrol 2009 5 319 328 10.1038/nrneph.2009.74 19474827
7. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. A Bohle GA Muller M Wehrmann S Mackensen-Haen JC Xiao, Kidney Int Suppl 1996 54 2 S9 8731185
8. Age-related increase in expression of TGF-beta1 in the rat kidney: relationship to morphologic changes. MP Ruiz-Torres RJ Bosch F O'Valle RG Del Moral C Ramírez M Masseroli C Pérez-Caballero MC Iglesias M Rodríguez-Puyol D Rodríguez-Puyol, J Am Soc Nephrol 1998 9 782 791 9596075
9. Chronic allograft nephropathy: An update. LC Paul, Kidney Int 1999 56 783 793 10.1046/j.1523-1755.1999.00611.x 10469349
10. Pathogenesis of renal injury in obstructive uropathy. RL Chevalier, Curr Opin Pediatr 2006 18 153 160 10.1097/01.mop.0000193287.56528.a4 16601495
11. Mediators of fibrosis and apoptosis in obstructive uropathies. R Misseri KK Meldrum, Curr Urol Rep 2005 6 140 145 10.1007/s11934-005-0083-5 15717973
12. Altered expression of immune modulator and structural genes in neonatal unilateral ureteral obstruction. DM Silverstein BR Travis BA Thornhill JS Schurr JK Kolls JC Leung RL Chevalier, Kidney Int 2003 64 25 35 10.1046/j.1523-1755. 2003.00067.x 12787392
13. Macrophage phenotype and renal fibrosis in obstructive nephropathy. M Nishida K Hamaoka, Nephron Exp Nephrol 2008 110 31 e36 10.1159/000151561 18724069
14. Naturally occurring NF-kappaB inhibitors. NH Nam, Mini Rev Med Chem 2006 6 945 951 10.2174/138955706777934937 16918500
15. The role of nuclear factor-kappa B in cytokine gene regulation. TS Blackwell JW Christman, Am J Respir Cell Mol Biol 1997 17 3 9 9224203
16. Activation of Erk1/2 and Akt following unilateral ureteral obstruction. AB Rodríguez-Pẽa MT Grande N Eleno M Arévalo C Guerrero E Santos JM Lápez-Novoa, Kidney Int 2008 74 196 209 10.1038/ki.2008.160 18449171
17. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. ON Ozes LD Mayo JA Gustin SR Pfeffer LM Pfeffer DB Donner, Nature 1999 401 82 85 10.1038/43466 10485710
18. Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. S Julien I Puig E Caretti J Bonaventure L Nelles F van Roy C Dargemont AG de Herreros A Bellacosa L Larue, Oncogene 2007 26 7445 7456 10.1038/sj.onc.1210546 17563753
19. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. HL Chua P Bhat-Nakshatri SE Clare A Morimiya S Badve H Nakshatri, Oncogene 2007 26 711 724 10.1038/sj.onc.1209808 16862183
20. NFkappaB mediates IL-1beta-induced down-regulation of TbetaRII through the modulation of Sp3 expression. C Bauge G Beauchef S Leclercq SJ Kim JP Pujol P Galéra K Boumédiene, J Cell Mol Med 2008 12 1754 1766 10.1111/j.1582-4934.2007.00173.x 18053089
21. Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. V Esteban O Lorenzo M Rupérez Y Suzuki S Mezzano J Blanco M Kretzler T Sugaya J Egido M Ruiz-Ortega, J Am Soc Nephrol 2004 15 1514 1529 10.1097/01.ASN.0000130564.75008.F5 15153562
22. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction. JJ Morrissey S Klahr, Kidney Int 1997 52 926 933 10.1038/ki.1997.414 9328931
23. Novel nuclear factor kappa B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction. A Miyajima T Kosaka K Seta T Asano K Umezawa M Hayakawa, J Urol 2003 169 1559 1563 10.1097/01.ju.0000045686.21766.c1 12629415
24. Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: possible role of nuclear factor kappaB. K Tashiro S Tamada N Kuwabara T Komiya K Takekida T Asai H Iwao K Sugimura Y Matsumura M Takaoka T Nakatani K Miura, Int J Mol Med 2003 12 587 592 12964039
25. TNF-alpha neutralization decreases nuclear factor-kappaB activation and apoptosis during renal obstruction. KK Meldrum P Metcalfe JA Leslie R Misseri KL Hile DR Meldrum, J Surg Res 2006 131 182 188 10.1016/j.jss.2005.11.581 16412467
26. Attenuation of renal fibrosis by curcumin in rat obstructive nephropathy. N Kuwabara S Tamada T Iwai K Teramoto N Kaneda T Yukimura T Nakatani K Miura, Urology 2006 67 440 446 10.1016/j.urology.2005.09.028 16461119
27. Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kappaB signaling. M Giannopoulou C Dai X Tan X Wen GK Michalopoulos Y Liu, Am J Pathol 2008 173 30 41 10.2353/ajpath.2008.070583 18502824
28. A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction. Y Mizuguchi J Chen SV Seshan DP Poppas HH Szeto D Felsen, Am J Physiol Renal Physiol 2008 295 1545 F1553 10.1152/ajprenal.00395.2007 18784263
29. The involvement of oxidative stress in the progression of renal injury. E Haugen KA Nath, Blood Purif 1999 17 58 65 10.1159/000014377 10449863
30. Advanced glycation end products and the progressive course of renal disease. A Heidland K Sebekova R Schinzel, Am J Kidney Dis 2001 38 100 S106 10.1053/ajkd.2001.27414 11576932
31. Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. N Kawada T Moriyama A Ando M Fukunaga T Miyata K Kurokawa E Imai M Hori, Kidney Int 1999 56 1004 1013 10.1046/j.1523-1755.1999.00612.x 10469368
32. Urinary tract obstruction. S Klahr, Semin Nephrol 2001 21 133 145 10.1053/snep.2001.20942 11245776
33. Antioxidant expression in experimental hydronephrosis: role of mechanical stretch and growth factors. SD Ricardo G Ding M Eufemio JR Diamond, Am J Physiol 1997 272 789 F798 9227641
34. Cytoprotective role of nitric oxide associated with Hsp70 expression in neonatal obstructive nephropathy. W Manucha PG Valles, Nitric Oxide 2008 18 204 215 10.1016/j.niox.2008.01.005 18280260
35. Dynamics and factors regulating the intensity of free radical processes during experimental supravesical block. EF Barinov EV Barabadze I Zhdaniuk Iu, Vopr Med Khim 1992 38 5 7 1492399
36. Suppression of AGE precursor formation following unilateral ureteral obstruction in mouse kidneys by transgenic expression of alpha-dicarbonyl/L- xylulose reductase. J Asami H Odani A Ishii K Oide T Sudo A Nakamura N Miyata N Otsuka K Maeda J Nakagawa, Biosci Biotechnol Biochem 2006 70 2899 2905 10.1271/bbb.60311 17151462
37. Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. T Moriyama N Kawada K Nagatoya M Takeji M Horio A Ando E Imai M Hori, Kidney Int 2001 59 2095 2103 11380811
38. Alpha-tocopherol modulates lipoprotein cytotoxicity in obstructive nephropathy. P Saborio RJ Krieg NB Kuemmerle EP Norkus CC Schwartz JC Chan, Pediatr Nephrol 2000 14 740 746 10.1007/PL00013428 10955918
39. Retinoid agonist isotretinoin ameliorates obstructive renal injury. M Schaier T Jocks HJ Grone E Ritz J Wagner, J Urol 2003 170 1398 1402 10.1097/01.ju.0000084620.64255.b3 14501777
40. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. DC Radisky DD Levy LE Littlepage H Liu CM Nelson JE Fata D Leake EL Godden DG Albertson MA Nieto Z Werb MJ Bissell, Nature 2005 436 123 127 10.1038/nature03688 16001073
41. Comparative effects of ACE inhibition and angiotensin II receptor blockade in the prevention of renal damage. S Klahr J Morrissey, Kidney Int Suppl 2002 23 S26 12410850
42. Angiotensin II-mediated renal injury. RC Harris M Martínez- Maldonado, Miner Electrolyte Metab 1995 21 328 335 7565481
43. Molecular and cellular pathophysiology of obstructive nephropathy. RL Chevalier, Pediatr Nephrol 1999 13 612 619 10.1007/s004670050756 10460514
44. Angiotensin II and gene expression in the kidney. S Klahr J Morrissey, Am J Kidney Dis 1998 31 171 176 10.1053/ajkd.1998.v31.pm9428470 9428470
45. Modulation of angiotensin II effects, a potential novel approach to inflammatory and immune diseases. M Ruiz-Ortega M Rupérez V Esteban J Rodríguez-Vita E Snchez-Lápez J Egido, Curr Med Chem 2003 2 379 394
46. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. G Wolf FN Ziyadeh F Thaiss J Tomaszewski RJ Caron U Wenzel G Zahner U Helmchen RA Stahl, J Clin Invest 1997 100 1047 1058 10.1172/JCI119615 9276721
47. Inflammation influences vascular remodeling through AT2 receptor expression and signaling. M Akishita M Horiuchi H Yamada L Zhang G Shirakami K Tamura Y Ouchi VJ Dzau, Physiol Genomics 2000 2 13 20 11015577
48. Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. M Ruiz-Ortega O Lorenzo M Rupérez J Blanco J Egido, Am J Pathol 2001 158 1743 1756 11337372
49. Effect of simultaneous blockade of AT1 and AT2 receptors on the NFkappaB pathway and renal inflammatory response. V Esteban M Rupérez JR Vita ES Lápez S Mezzano JJ Plaza J Egido M Ruiz-Ortega, Kidney Int Suppl 2003 33 S38 10.1046/j.1523-1755.64.s86.7.x 12969125
50. Role of renin-angiotensin system and nuclear factor-kappaB in the obstructed kidney of rats with unilateral ureteral obstruction. T Nakatani S Tamada T Asai Y Iwai T Kim T Tsujino N Kumata J Uchida K Tashiro N Kuwabara T Komiya T Sumi M Okamura K Miura, Jpn J Pharmacol 2002 90 361 364 10.1254/jjp.90.361 12501014
51. Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. M Satoh N Kashihara Y Yamasaki K Maruyama K Okamoto Y Maeshima H Sugiyama T Sugaya K Murakami H Makino, J Am Soc Nephrol 2001 12 317 325 11158221
52. Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction. D Kellner J Chen I Richardson SV Seshan M El Chaar ED Vaughan Jr D Poppas D Felsen, J Urol 2006 176 806 812 10.1016/j.juro.2006.03.076 16813952
53. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. M Nishida H Fujinaka T Matsusaka J Price V Kon AB Fogo JM Davidson MF Linton S Fazio T Homma H Yoshida I Ichikawa, J Clin Invest 2002 110 1859 1868 12488436
54. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. S Ishidoya J Morrissey R McCracken A Reyes S Klahr, Kidney Int 1995 47 1285 1294 10.1038/ki.1995.183 7637258
55. Is enalapril adequate for the prevention of renal tissue damage caused by unilateral ureteral obstruction and/or hyperoxaluria? T Turan JG van Harten R de Water OL Tuncay DJ Kok, Urol Res 2003 31 212 217 10.1007/s00240-003-0320-7 12719949
56. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. K Nagatoya T Moriyama N Kawada M Takeji S Oseto T Murozono A Ando E Imai M Hori, Kidney Int 2002 61 1684 1695 10.1046/j.1523-1755.2002.00328.x 11967018
57. Turmeric-based diet can delay apoptosis without modulating NF-kappaB in unilateral ureteral obstruction in rats. RM Hashem HM Soliman SF Shaapan, J Pharm Pharmacol 2008 60 83 89 10.1211/jpp.60.1.0011 18088509
58. Testosterone exacerbates obstructive renal injury by stimulating TNF-alpha production and increasing proapoptotic and profibrotic signaling. PD Metcalfe JA Leslie MT Campbell DR Meldrum KL Hile KK Meldrum, Am J Physiol Endocrinol Metab 2008 294 435 E443 10.1152/ajpendo.00704.2006 18073317
59. Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy. H Yamagishi T Yokoo T Imasawa JS Shen Y Hisada Y Eto T Kawamura T Hosoya, J Immunol 2001 166 609 616 11123344
60. TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. R Misseri DR Meldrum CA Dinarello P Dagher KL Hile RC Rink KK Meldrum, Am J Physiol Renal Physiol 2005 288 406 F411 10.1152/ajprenal.00099.2004 15507546
61. Unilateral ureteral obstruction induces renal tubular cell production of tumor necrosis factor-alpha independent of inflammatory cell infiltration. R Misseri DR Meldrum P Dagher K Hile RC Rink KK Meldrum, J Urol 2004 172 1595 1599 10.1097/01.ju.0000138902.57626.70 15371768
62. Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction. X Dong LA Bachman MN Miller KA Nath MD Griffin, Kidney Int 2008 74 1294 1309 10.1038/ki.2008.394 18974760
63. Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling. X Tan X Wen Y Liu, J Am Soc Nephrol 2008 19 1741 1752 10.1681/ASN.2007060666 18525004
64. Macrophage accumulation and renal fibrosis are independent of macrophage migration inhibitory factor in mouse obstructive nephropathy. EK Rice DJ Nikolic-Paterson JR David R Bucala CN Metz RC Atkins GH Tesch, Nephrology (Carlton) 2004 9 278 287 10.1111/j.1440-1797.2004.00319.x 15504140
65. Macrophages and progressive renal disease in experimental hydronephrosis. JR Diamond, Am J Kidney Dis 1995 26 133 140 10.1016/0272-6386(95)90166-3 7611244
66. Chronic obstructive uropathy in severe combined immunodeficient (SCID) mice: lymphocyte infiltration is not required for progressive tubulointerstitial injury. SB Shappell T Gurpinar J Lechago WN Suki LD Truong, J Am Soc Nephrol 1998 9 1008 1017 9621283
67. Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. JR Diamond D Kees-Folts G Ding JE Frye NC Restrepo, Am J Physiol 1994 266 926 F933 7517644
68. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. NC Henderson AC Mackinnon SL Farnworth T Kipari C Haslett JP Iredale FT Liu J Hughes T Sethi, Am J Pathol 2008 172 288 298 10.2353/ajpath.2008.070726 18202187
69. Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. SL Lin AP Castão BT Nowlin ML Lupher Jr JS Duffield, J Immunol 2009 183 6733 6743 10.4049/jimmunol.0901473 19864592
70. Mast cells decrease renal fibrosis in unilateral ureteral obstruction. DH Kim SO Moon YJ Jung AS Lee KP Kang TH Lee S Lee OH Chai CH Song KY Jang MJ Sung X Zhang SK Park W Kim, Kidney Int 2009 75 1031 1038 10.1038/ki.2009.1 19242503
71. Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. B Lange-Sperandio A Trautmann O Eickelberg A Jayachandran S Oberle F Schmidutz B Rodenbeck M Hömme R Horuk F Schaefer, Am J Pathol 2007 171 861 871 10.2353/ajpath.2007.061199 17675578
72. Effects of liposome clodronate on renal leukocyte populations and renal fibrosis in murine obstructive nephropathy. K Kitamoto Y Machida J Uchida Y Izumi M Shiota T Nakao H Iwao T Yukimura T Nakatani K Miura, J Pharmacol Sci 2009 111 285 292 10.1254/jphs.09227FP 19893275
73. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. TA Springer, Cell 1994 76 301 314 10.1016/0092-8674(94) 90337-9 7507411
74. L-selectin and its ligands mediate infiltration of mononuclear cells into kidney interstitium after ureteric obstruction. K Shikata Y Suzuki J Wada K Hirata M Matsuda H Kawashima T Suzuki M Iizuka H Makino M Miyasaka, J Pathol 1999 188 93 99 10.1002/(SICI)1096-9896(199905)188:1<93::AID-PATH305>3.0. CO;2-# 10398147
75. P-selectin-dependent macrophage migration into the tubulointerstitium in unilateral ureteral obstruction. T Naruse Y Yuzawa T Akahori M Mizuno S Maruyama R Kannagi N Hotta S Matsuo, Kidney Int 2002 62 94 105 10.1046/j.1523-1755.2002. 00419.x 12081568
76. Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice. B Lange-Sperandio F Cachat BA Thornhill RL Chevalier, Kidney Int 2002 61 516 524 10.1046/j.1523-1755.2002.00162.x 11849391
77. Cerebroside sulfotransferase deficiency ameliorates L-selectin-dependent monocyte infiltration in the kidney after ureteral obstruction. D Ogawa K Shikata K Honke S Sato M Matsuda R Nagase A Tone S Okada H Usui J Wada M Miyasaka H Kawashima Y Suzuki T Suzuki N Taniguchi Y Hirahara K Tadano-Aritomi I Ishizuka TF Tedder H Makino, J Biol Chem 2004 279 2085 2090 10.1074/jbc.M305809200 14583626
78. Expression of adhesion molecules in kidney with experimental chronic obstructive uropathy: the pathogenic role of ICAM-1 and VCAM-1. SB Shappell LH Mendoza T Gurpinar CW Smith WN Suki LD Truong, Nephron 2000 85 156 166 10.1159/000045649 10867522
79. Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis. JJ Morrissey S Klahr, Am J Physiol 1998 274 580 F586 9530275
80. Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. SD Ricardo ME Levinson MR DeJoseph JR Diamond, Kidney Int 1996 50 2002 2010 10.1038/ki.1996.522 8943483
81. Role of leukocyte adhesion molecules in monocyte/macrophage infiltration in weanling rats with unilateral ureteral obstruction. A Takeda A Fukuzaki H Kaneto S Ishidoya Y Ogata T Sasaki R Konda K Sakai S Orikasa, Int J Urol 2000 7 415 420 10.1046/j.1442-2042.2000.00222.x 11144652
82. Effects of ICAM-1 antisense oligonucleotide on the tubulointerstitium in mice with unilateral ureteral obstruction. QL Cheng XM Chen F Li HL Lin YZ Ye B Fu, Kidney Int 2000 57 183 190 10.1046/j.1523-1755.2000.00825.x 10620199
83. Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling. K Hu C Wu WM Mars Y Liu, J Clin Invest 2007 117 3821 3832 10.1172/JCI32405 18037995
84. Distinct roles of Mac-1 and its counter-receptors in neonatal obstructive nephropathy. B Lange-Sperandio K Schimpgen B Rodenbeck T Chavakis A Bierhaus P Nawroth B Thornhill F Schaefer RL Chevalier, Kidney Int 2006 69 81 88 10.1038/sj.ki.5000017 16374427
85. Urokinase receptor modulates cellular and angiogenic responses in obstructive nephropathy. G Zhang H Kim X Cai JM Lopez-Guisa P Carmeliet AA Eddy, J Am Soc Nephrol 2003 14 1234 1253 10.1097/01.ASN.0000064701.70231.3F 12707393 (Pubitemid 36514665)
86. Neutrophil transmigration under shear flow conditions in vitro is junctional adhesion molecule-C independent. M Sircar PF Bradfield M Aurrand-Lions RJ Fish P Alcaide L Yang G Newton D Lamont S Sehrawat T Mayadas TW Liang CA Parkos BA Imhof FW Luscinskas, J Immunol 2007 178 5879 5887 17442972
87. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. V Vielhauer HJ Anders M Mack J Cihak F Strutz M Stangassinger B Luckow HJ Gröne D Schlöndorff, J Am Soc Nephrol 2001 12 1173 1187 11373340
88. mRNA expression of chemokines in rat kidneys with ureteral obstruction. H Kaneto A Fukuzaki S Ishidoya A Takeda Y Ogata T Sasaki S Yamada S Orikasa, Nippon Hinyokika Gakkai Zasshi 2000 91 69 74 10723179
89. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. V Vielhauer HJ Anders M Mack J Cihak F Strutz M Stangassinger B Luckow HJ Gröne D Schlöndorff, J Am Soc Nephrol 2001 12 1173 1187 11373340
90. Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. T Wada K Furuichi N Sakai Y Iwata K Kitagawa Y Ishida T Kondo H Hashimoto Y Ishiwata N Mukaida N Tomosugi K Matsushima K Egashira H Yokoyama, J Am Soc Nephrol 2004 15 940 948 10.1097/01.ASN.0000120371.09769.80 15034096 (Pubitemid 38375313)
91. MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates. ST Pittock SM Norby JP Grande AJ Croatt GD Bren AD Badley NM Caplice MD Griffin KA Nath, Kidney Int 2005 68 611 622 10.1111/j.1523-1755.2005.00439.x 16014038
92. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. V Eis B Luckow V Vielhauer JT Siveke Y Linde S Segerer G Pérez De Lema CD Cohen M Kretzler M Mack R Horuk PM Murphy JL Gao KL Hudkins CE Alpers HJ Gröne D Schlöndorff HJ Anders, J Am Soc Nephrol 2004 15 337 347 10.1097/01.ASN.0000111246.87175.32 14747380
93. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. HJ Anders V Vielhauer M Frink Y Linde CD Cohen SM Blattner M Kretzler F Strutz M Mack HJ Gröne J Onuffer R Horuk PJ Nelson D Schlöndorff, J Clin Invest 2002 109 251 259 11805137
94. Blockade of CCR2 ameliorates progressive fibrosis in kidney. K Kitagawa T Wada K Furuichi H Hashimoto Y Ishiwata M Asano M Takeya WA Kuziel K Matsushima N Mukaida H Yokoyama, Am J Pathol 2004 165 237 246 15215179
95. Chemokine expression in the obstructed kidney. JM Crisman LL Richards DP Valach DF Franzoni JR Diamond, Exp Nephrol 2001 9 241 248 10.1159/000052618 11423723
96. Blockade of IP-10/CXCR3 promotes progressive renal fibrosis. I Nakaya T Wada K Furuichi N Sakai K Kitagawa H Yokoyama Y Ishida T Kondo T Sugaya H Kawachi F Shimizu S Narumi M Haino C Gerard K Matsushima S Kaneko, Nephron Exp Nephrol 2007 107 12 21 10.1159/000106505 (Pubitemid 47355797)
97. TGF-beta and epithelial-to-mesenchymal transitions. J Zavadil EP Böttinger, Oncogene 2005 24 5764 5774 10.1038/sj.onc.1208927 16123809
98. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. A Boutet CA De Frutos PH Maxwell MJ Mayol J Romero MA Nieto, EMBO J 2006 25 5603 5613 10.1038/sj.emboj.7601421 17093497
99. Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice. LJ Ma H Yang A Gaspert G Carlesso MM Barty JM Davidson D Sheppard AB Fogo, Am J Pathol 2003 163 1261 1273 14507636
100. Quantification of TGF-beta1 mRNA along rat nephron in obstructive nephropathy. K Fukuda K Yoshitomi T Yanagida M Tokumoto H Hirakata, Am J Physiol Renal Physiol 2001 281 513 F521 11502600
101. TGF-beta and glomerulonephritis: anti-inflammatory versus prosclerotic actions. M Kitamura TS Suto, Nephrol Dial Transplant 1997 12 669 679 10.1093/ndt/12.4.669 9140992
102. Transforming growth factor type induces monocyte chemotaxis and growth factor production. SM Wahl DA Hunt LM Wakefield N McCartney-Francis LM Wahl AB Roberts MB Sporn, Proc Natl Acad Sci USA 1987 84 5788 5792 10.1073/pnas.84.16. 5788 2886992
103. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. W Wang XR Huang AG Li F Liu JH Li LD Truong XJ Wang HY Lan, J Am Soc Nephrol 2005 16 1371 1383 10.1681/ASN.2004121070 15788474
104. Leptin is a coactivator of TGF-beta in unilateral ureteral obstructive kidney disease. P Kumpers F Gueler S Rong M Mengel I Tossidou I Peters H Haller M Schiffer, Am J Physiol Renal Physiol 2007 293 1355 F1362 10.1152/ajprenal. 00003.2007 17686962
105. Hepatocyte growth factor and the kidney: it is not just for the liver. DF Balkovetz JH Lipschutz, Int Rev Cytol 1999 186 225 260 full-text 9770301
106. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. S Mizuno K Matsumoto T Nakamura, Kidney Int 2001 59 1304 1314 10.1046/j.1523-1755.2001.0590041304.x 11260391
107. Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. X Gao H Mae N Ayabe T Takai K Oshima M Hattori T Ueki J Fujimoto T Tanizawa, Kidney Int 2002 62 1238 1248 10.1111/j.1523-1755.2002. kid579.x 12234294
108. Nuclear factor kappaB for the nephrologist. EN Wardle, Nephrol Dial Transplant 2001 16 1764 1768 10.1093/ndt/16.9.1764 11522856
109. Tubulointerstitial macrophage accumulation is regulated by sequentially expressed osteopontin and macrophage colony-stimulating factor: implication for the role of atorvastatin. S Tian G Ding R Jia G Chu, Mediators Inflamm 2006 2006: Article ID 12919, 9 pages. 16883060
110. Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. DM Lenda E Kikawada ER Stanley VR Kelley, J Immunol 2003 170 3254 3262 12626584
111. A2A adenosine receptor agonist and PDE4 inhibition delays inflammation but fails to reduce injury in experimental obstructive nephropathy. B Lange-Sperandio MS Forbes B Thornhill MD Okusa J Linden RL Chevalier, Nephron Exp Nephrol 2005 100 113 e123 10.1159/000085057 15824514
112. Adenosine inhibits macrophage colony-stimulating factor-dependent proliferation of macrophages through the induction of p27kip-1 expression. J Xaus AF Valledor M Cardo L Marquès J Beleta JM Palacios A Celada, J Immunol 1999 163 4140 4149 10510349
113. Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. U Panzer F Thaiss G Zahner P Barth M Reszka RR Reinking G Wolf U Helmchen RA Stahl, Kidney Int 2001 59 1762 1769 10.1046/j.1523-1755.2001.0590051762.x 11318946
114. Expression, roles, receptors, and regulation of osteopontin in the kidney. Y Xie M Sakatsume S Nishi I Narita M Arakawa F Gejyo, Kidney Int 2001 60 1645 1657 10.1046/j.1523-1755.2001.00032.x 11703581
115. Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. VP Persy A Verhulst DK Ysebaert KE De Greef ME De Broe, Kidney Int 2003 63 543 553 10.1046/j.1523-1755.2003.00767.x 12631119
116. Osteopontin expression in the kidney during unilateral ureteral obstruction. H Kaneto J Morrissey R McCracken A Reyes S Klahr, Miner Electrolyte Metab 1998 24 227 237 10.1159/000057375 9554561
117. Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. V Ophascharoensuk CM Giachelli K Gordon J Hughes R Pichler P Brown L Liaw R Schmidt SJ Shankland CE Alpers WG Couser RJ Johnson, Kidney Int 1999 56 571 580 10.1046/j.1523-1755.1999.00580.x 10432396
118. CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. KM Rouschop ME Sewnath N Claessen JJ Roelofs I Hoedemaeker R van der Neut J Aten ST Pals JJ Weening S Florquin, J Am Soc Nephrol 2004 15 674 686 10.1097/01.ASN.0000115703.30835.96 14978169
119. Regulation of proximal tubular osteopontin in experimental hydronephrosis in the rat. JR Diamond R Kreisberg R Evans TA Nguyen SD Ricardo, Kidney Int 1998 54 1501 1509 10.1046/j.1523-1755.1998.00137.x 9844126
120. Angiotensinogen and AT(1) antisense inhibition of osteopontin translation in rat proximal tubular cells. SD Ricardo DF Franzoni CD Roesener JM Crisman JR Diamond, Am J Physiol Renal Physiol 2000 278 708 F716 10807582
121. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. JM Vieira Jr E Mantovani LT Rodrigues H Dell IL Noronha CK Fujihara R Zatz, Nephrol Dial Transplant 2005 20 1582 1591 10.1093/ndt/gfh859 15855201
122. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects. JK Park DN Muller EM Mervaala R Dechend A Fiebeler F Schmidt M Bieringer O Schäfer C Lindschau W Schneider D Ganten FC Luft H Haller, Kidney Int 2000 58 1420 1430 10.1046/j.1523-1755.2000.00304.x 11012877
123. Statins: effects beyond cholesterol lowering. ZA Massy C Guijarro, Nephrol Dial Transplant 2001 16 1738 1741 10.1093/ndt/16.9.1738 11522848
124. Mizoribine ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. N Sato K Shiraiwa K Kai A Watanabe S Ogawa Y Kobayashi H Yamagishi-Imai Y Utsunomiya T Mitarai, Nephron 2001 89 177 185 10.1159/000046065 11549900
125. Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction. KH Yoo BA Thornhill MS Forbes CM Coleman ES Marcinko L Liaw RL Chevalier, Kidney Int 2006 70 1735 1741 10.1038/sj.ki.5000357 17003824
126. Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent. AB Tuck C Hota AF Chambers, Breast Cancer Res Treat 2001 70 197 204 10.1023/A:1013095329825 11804183
127. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. R Das GH Mahabeleshwar GC Kundu, J Biol Chem 2003 278 28593 28606 10.1074/jbc.M303445200 12771144
128. Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. A Musial NT Eissa, J Biol Chem 2001 276 24268 24273 10.1074/jbc.M100725200 11312270
129. Early upregulation of iNOS mRNA expression and increase in NO metabolites in pressurized renal epithelial cells. NV Broadbelt PJ Stahl J Chen M Mizrahi A Lal A Bozkurt DP Poppas D Felsen, Am J Physiol Renal Physiol 2007 293 1877 F1888 10.1152/ajprenal.00238.2007 17881462
130. Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase. D Hochberg CW Johnson J Chen D Cohen J Stern ED Vaughan Jr D Poppas D Felsen, Lab Invest 2000 80 1721 1728 10.1038/labinvest.3780182 11092532
131. Losartan modulation on NOS isoforms and COX-2 expression in early renal fibrogenesis in unilateral obstruction. W Manucha L Oliveros L Carrizo A Seltzer P Vallés, Kidney Int 2004 65 2091 2107 10.1111/j.1523-1755.2004.00643.x 15149322
132. Liposome-mediated transfer of nitric oxide synthase gene improves renal function in ureteral obstruction in rats. K Ito J Chen JJ Khodadadian SV Seshan C Eaton X Zhao ED Vaughan Jr M Lipkowitz DP Poppas D Felsen, Kidney Int 2004 66 1365 1375 10.1111/j.1523-1755.2004.00899.x 15458429
133. Promise for gene therapy in obstructive nephropathy. RL Chevalier, Kidney Int 2004 66 1709 1710 10.1111/j.1523-1755.2004.00984.x 15458470
134. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy. JT Wu JG Kral, J Surg Res 2005 123 158 169 10.1016/j.jss.2004. 06.006 15652965
135. Molecular mechanisms and therapeutic strategies of chronic renal injury: the role of nuclear factor kappaB activation in the development of renal fibrosis. S Tamada T Asai N Kuwabara T Iwai J Uchida K Teramoto N Kaneda T
136. Effects of mycophenolate mofetil and lisinopril on collagen deposition in unilateral ureteral obstruction in rats. RG Goncalves MA Biato RD Colosimo CA Martinusso ID Pecly EK Farias LR Cardoso CM Takiya JF Ornellas M Leite Jr, Am J Nephrol 2004 24 527 536 10.1159/000081706 15499219
137. Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. MJ Wu MC Wen YT Chiu YY Chiou KH Shu MJ Tang, Kidney Int 2006 69 2029 2036 10.1038/sj.ki.5000161 16732193